Home  >  Products  >  CD151 (CD151 molecule (Raph blood group)) Blocking Peptide (the C terminal of CD151)(100ug)
CD151 (CD151 molecule (Raph blood group)) Blocking Peptide (the C terminal of CD151)(100ug)

CD151 (CD151 molecule (Raph blood group)) Blocking Peptide (the C terminal of CD151)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CD151 Antibody (ARP63500_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63500
Size: 100ug
Weight: 28kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. It is involved in cellular processes including cell adhesion and may regulate integrin trafficking and/or function. This protein enhances cell motility, invasion and metastasis of cancer cells. Multiple alternatively spliced transcript variants that encode the same protein have been described for this gene.
Alternative names: GP27; MER2; PETA-3; RAPH; SFA1; TSPAN24
See Full Product Listings >